- 21 Feb 2002
- IOC News
Clarification regarding Doping Control Measures
SALT LAKE CITY, Utah (21 February 2002)- The International Olympic Committee wants to clarify a number of items regarding the blood screening and doping control procedures carried out during the 2002 Olympic Winter Games:
- As it declared publicly last year, the IOC and SLOC are screening the blood of all endurance athletes before they compete. According to the applicable IF rules, athletes who are found to have abnormal blood parameters are not allowed to start their competition and are submitted to further testing. The determination of abnormal blood parameters does not constitute a doping offense.
Today, two athletes competing in cross country, one Russian and one Ukrainian, were found to have higher than allowed levels of hemoglobin. Consequently, they were not allowed by FIS to start their competitions. They have submitted to further testing, but the results of these tests are not yet available.
- The IOC has been working to reduce the number of athletes using beta-2 agonists during the Olympic Games. Last year, the IOC announced more stringent regulations to limit their use. Athletes who applied to use these substances to combat asthma or exercise-induced asthma must have submitted a written request with support of a medical diagnosis for these conditions by January 28, 2002. An independent panel assessed the diagnoses and made recommendations to the IOC Medical Commission. As a result of these stiffer regulations, 25 applications, or nearly 20 percent, were denied.